Evidence map›Paper›PMID 33364795›Full record

ArticleInfection and drug resistance2020

Molecular Characterization of Carbapenem/Colistin-Resistant

Nevine S Fam, Doaa Gamal, Sara H Mohamed, Reham M Wasfy, May S Soliman, Amani A El-Kholy, Paul G Higgins

Abstract read
In one paragraph

Article in Infection and drug resistance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Colistin-resistance amongJAC-antimicrobial resistance · 2026
    Review
  3. Molecular Characterization of Colistin-Resistant ClinicalAntibiotics (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Global emergence ofMicrobial genomics · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. TracingMicroorganisms · 2024
    Article
  10. Article
  11. Laboratory Surveillance ofTropical medicine and infectious disease · 2023
    Article
  12. Three separate acquisitions of blaEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  13. Antibiotics (Basel, Switzerland) · 2023
    Article
  14. Colistin Resistance inAntibiotics (Basel, Switzerland) · 2023
    Review
  15. Molecular characterization of multidrug resistantFrontiers in cellular and infection microbiology · 2023
    Article
  16. Retained colistin susceptibility in clinicalFrontiers in cellular and infection microbiology · 2023
    Article
  17. Genomic characterization of an NDM-9-producingFrontiers in microbiology · 2023
    Article
  18. Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2023
    Review
  19. Molecular Characterization of Carbapenem-ResistantInfection and drug resistance · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nevine S FamDepartment of Microbiology, Theodor Bilharz Research Institute, Giza, Egypt.
Doaa GamalDepartment of Microbiology, Theodor Bilharz Research Institute, Giza, Egypt.
Sara H MohamedDepartment of Microbiology, National Organization for Drug Control and Research, Giza, Egypt.ORCID 0000-0003-1379-6493
Reham M WasfyDepartment of Microbiology, Theodor Bilharz Research Institute, Giza, Egypt.
May S SolimanClinical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.ORCID 0000-0002-2818-0889
Amani A El-KholyClinical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.ORCID 0000-0002-0645-7664
Paul G HigginsInstitute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne 50935, Germany.ORCID 0000-0001-8677-9454

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe rise of carbapenem-resistant MATERIALS AND

methodsSeventeen clinically recovered

resultsAbout 52.9% (9/17) were colistin-resistant. PCR results revealed that all isolates carried

conclusionThe emergence and high incidence of colistin-resistance among CRAB clinical isolates in Egypt are alarming because it further limits therapy options and requires prudent antimicrobial stewardship and stringent infection control measures. Whole-genome sequence analyses suggest that the resistance to colistin was associated with multiple mutations in the

Indexed as

cgMLSTcolistin resistancepmrCABST158WGS

Identifiers

PMID33364795
PMCPMC7751577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.